Latest News and Press Releases

CAMBRIDGE, Mass., July 26, 2022 (GLOBE NEWSWIRE) -- Rubius Therapeutics, Inc. (Nasdaq: RUBY), a clinical-stage biopharmaceutical company that is biologically engineering red blood cells to create an...

SAN DIEGO, July 26, 2022 (GLOBE NEWSWIRE) -- Beam Global, (Nasdaq: BEEM, BEEMW), the leading provider of innovative sustainable products and technologies for electric vehicle (EV) charging, energy...

Second Quarter 2022 Results: Total revenue increased 2% from Q2 2021 or 13% linked-quarter annualizedNet interest income (tax-equivalent) increased 6% from Q2 2021 No provision for loan losses,...

WARREN, N.J., July 26, 2022 (GLOBE NEWSWIRE) -- Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing medicines to solve patients' problems with current standards of care...

— FDA feedback marks a key milestone in the construction of the facility expected to support AGTC’s pipeline, including the late-stage development and potential commercialization of AGTC’s X-Linked...

COLUMBUS, Ohio, July 26, 2022 (GLOBE NEWSWIRE) -- Core Molding Technologies, Inc. (NYSE American: CMT) (“Core Molding”, “Core” or the “Company”), a leading engineered materials company specializing...

NEW YORK, July 26, 2022 (GLOBE NEWSWIRE) -- Getty Images Holdings, Inc. (“Getty Images”) (NYSE: GETY) a preeminent global visual content creator and marketplace, announced today that the company...

Bloomington, Ind., July 26, 2022 (GLOBE NEWSWIRE) -- Solution Tree, a leading educational publisher and professional development provider, announced today the selection of Calvin L. Daniels as...

BELLINGHAM, Wash., July 26, 2022 (GLOBE NEWSWIRE) -- eXp World Holdings, Inc. (Nasdaq: EXPI), the holding company for eXp Realty®, Virbela and SUCCESS® Enterprises, today announced it will report...

MoonLake Immunotherapeutics signs development and manufacturing agreement with Vetter Pharma International GmbH ZUG, Switzerland, July 26, 2022 – MoonLake Immunotherapeutics AG (MoonLake; Nasdaq:...